allowed stem cell transplant multiple myeloma mm one treatment assoc longterm diseasefre survive high rcid treatmentrel mortal recaps howe import reason controversy role allograft manga review result span period year order better define outcome identify area progress well require improv total patient receive marrow pbcs highs myeloabl n reduce intent nonmyeloabl regimen cultivar analysis adjust differ patient group intensitynonmyeloabl transplant significantly le act vhd lower pf overall signifies recaps progress chronic adjust receive decrease prior autograph Î² microglobulin influence tandem 